Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

Please sign in to follow a disease.

← Back to home

Rycarma Therapeutics, Inc.

Clinical trials sponsored by Rycarma Therapeutics, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug hopes to strengthen muscles in rare genetic disorder Results expected Aug 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New drug hopes to strengthen muscles in rare genetic disorder

Disease control Recruiting now

This study tests a medicine called surlorian in 28 adults with a rare genetic muscle disease (RYR1-related myopathy) that causes weakness. The goal is to see if surlorian improves muscle strength and function, like standing from a chair or walking. Participants will be randomly a…

Phase 2 • Sponsor: RyCarma Therapeutics, Inc. • Aim: Disease control

Last updated Jul 17, 2026 00:00 UTC